Responses to parliamentary questions
Question from Deputy Ryan O’Meara - PQ 51755-26
Deputy O'Meara asked if a pricing and reimbursement application has been received by the HSE for zolbetuximab (vyloy). Read the HSE response.
From: Communications and public affairs
Published: July 2026
Updated: July 2026
Documents
Summary
To ask the Minister for Health if a pricing and reimbursement application has been received by the HSE for zolbetuximab (vyloy); and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it